nach oben

Pharmaceutical Medicine

Erschienen in:

01.12.2011 | Adis Profile Summary

Drugs in Clinical Development for Prostate Cancer

Summary and Table

Erschienen in: Pharmaceutical Medicine | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Excerpt

Prostate cancer is the second most commonly diagnosed malignancy in men. In 2008, around 910000 men worldwide were estimated to be newly diagnosed with prostate cancer. The incidence of the disease is expected to almost double by 2030. However, mortality from prostate cancer is declining in some developed countries, partly because of early detection and improved treatment. …

Titel: Drugs in Clinical Development for Prostate Cancer
Summary and Table
Publikationsdatum: 01.12.2011
Verlag: Springer International Publishing
Erschienen in: Pharmaceutical Medicine / Ausgabe 6/2011
Print ISSN: 1178-2595
Elektronische ISSN: 1179-1993
DOI: https://doi.org/10.1007/BF03256882

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2011

Acknowledgement

How the Biopharmaceutical Industry Can Navigate a Healthcare Ecosystem Increasingly Driven by Demands for Comparative Effectiveness Research

Journal Watch

The Impact of Nonadherence to Inhaled Long-Acting β2-Adrenoceptor Agonist/Corticosteroid Combination Therapy on Healthcare Costs in Difficult-to-Control Asthma

Forum

Major Pharmaceutical Conferences and Courses